NanoViricides
NNVC
#10253
Rank
A$28.49 M
Marketcap
A$1.32
Share price
-5.59%
Change (1 day)
-31.49%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of September 2025 : A$1.63 Million

According to NanoViricides's latest financial reports the company has A$1.63 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-06-30A$2.36 M-67.04%
2024-06-30A$7.18 M-41.22%
2023-06-30A$12.22 M-40.03%
2022-06-30A$20.39 M-25.47%
2021-06-30A$27.36 M37.77%
2020-06-30A$19.86 M445.93%
2019-06-30A$3.63 M-61.97%
2018-06-30A$9.56 M-51.36%
2017-06-30A$19.66 M-39.37%
2016-06-30A$32.43 M-20.69%
2015-06-30A$40.89 M5.09%
2014-06-30A$38.91 M155.17%
2013-06-30A$15.25 M9.43%
2012-06-30A$13.93 M61.95%
2011-06-30A$8.6 M4.8%
2010-06-30A$8.21 M293.23%
2009-06-30A$2.08 M144.65%
2008-06-30A$0.85 M-25.32%
2007-06-30A$1.14 M-66.28%
2006-06-30A$3.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
A$13.98 B 853,849.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$21.19 B 1,293,750.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$15.52 B 948,012.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$6.18 B 377,820.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$1.06 B 65,199.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.39 B 24,306.55%๐Ÿ‡บ๐Ÿ‡ธ USA